Transcriptomics

Dataset Information

0

Integrative multi-omics landscape of fluoxetine action across 27 brain regions [bulk RNA-seq]


ABSTRACT: We constructed a comprehensive multi-omics map of the molecular effects of fluoxetine (an SSRI antidepressant), in 27 rat brain regions. We profiled gene expression (bulk RNA-seq, 210 datasets) and chromatin state (bulk chromatin immunoprecipitation sequencing (ChIP-seq) for the histone marker H3K27ac, 100 datasets) in a broad, unbiased panel of 27 brain regions across the entire rodent brain, in naive and fluoxetine-treated animals. We complemented this approach with single-cell RNA-seq (scRNA-seq) analysis of two brain regions. Using diverse integrative data analysis techniques we characterized the complex and multifaceted effects of fluoxetine on region-specific and cell-type-specific gene regulatory networks and pathways. Remarkably, we observed profound molecular changes across the brain (>4,000 differentially expressed genes and differentially acetylated ChIP-seq peaks each) that were highly region-dependent. We leveraged this atlas to identify fluoxetine-moduated genes and gene-regulatory loci, predict enriched motifs that suggest potential upstream regulators, and validate global mechanisms of fluoxetine action.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE194289 | GEO | 2022/09/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-04 | GSE193040 | GEO
2022-09-04 | GSE197622 | GEO
| PRJNA800072 | ENA
| PRJNA794169 | ENA
2016-01-22 | GSE67203 | GEO
| PRJNA811225 | ENA
| MSV000090283 | MassIVE
2012-09-06 | E-GEOD-31712 | biostudies-arrayexpress
2022-05-06 | GSE202172 | GEO
2022-06-06 | GSE205325 | GEO